Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol

Author(s):  McKettrick Greg, Yoch Doug

Issue:  Jan/Feb 2021 - Volume 25, Number 1
View All Articles in Issue

Page(s):  18-23

Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol Page 1
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol Page 2
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol Page 3
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol Page 4
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol Page 5
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol Page 6

Download in electronic PDF format for $65

Abstract:  Although prostatectomy and radiotherapy yield excellent- long term survival rates for men with prostate cancer, adverse effects (erectile dysfunction and/or urinary incontinence with subsequent undesired lifestyle modifications, anxiety about the loss of intimacy, negative self-perception, and the effects of such stressors on work performance and family relationships) frequently afflict patients who have undergone these procedures. Surgeons who specialize in the treatment of prostate cancer are dedicated to ensuring the optimal clinical result but often do not provide information about the likelihood of experiencing those sequelae or the additional support and aftercare necessary to ensure posttreatment sexual and urologic function to their patients’ satisfaction. In response to the needs of these underserved patients, the authors designed the Stanley Prostate-cancer Treatment Protocol for erectile dysfunction and urinary incontinence. The goal of the Stanley Protocol is to achieve an improved outcome after surgery or radiation therapy for prostate cancer via comprehensive therapy, patient monitoring, and detailed training. Each Protocol program is customized to address the individual patient’s needs as he attains his desired level of sexual function and urinary control. Feedback consistently indicates that patients who participate in the Stanley Protocol achieve those goals, and the authors suggest that this program can be incorporated into any compounding practice to provide the same result. In this article, the most common questions that compounders ask about the Stanley Protocol are answered, an outline of that therapeutic guideline is presented, and formulations proven to optimize the outcome of prescribed treatment are provided.

Related Keywords: Greg McKettrick, RPh, Doug Yoch, PharmD, men, male sexual dysfunction, erectile dysfunction, urinary incontinence, prostatectomy, prostatic radiotherapy, prostate cancer, adverse effects, emotional stress, anxiety, lifestyle changes, post-treatment sexual function, quality of life, Stanley Protocol, formulations, prostaglandin E1, phentolamine mesylate, papaverine hydrochloride, Trimix injection, sterile compounding, compounded sterile preparations, phosphodiesterase 5, PDE5, tadalafil, nitric oxide, Kegel exercises, vacuum erection device, sildenafil, penile injection

Related Categories: ENVIRONMENTAL , HISTORY, LEGAL, STERILE PREPARATIONS, QUALITY CONTROL

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
McKettrick Greg
, Yoch Doug
Jan/Feb 2021
Pg. 18-23

The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report
McKettrick Greg
, Yoch Doug
Mar/Apr 2021
Pg. 94-98

Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes
Fields Shannon W
Mar/Apr 2007
Pg. 122-124

Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction.
Trissel Lawrence A
, Zhang Yanping
May/Jun 2004
Pg. 231-235

Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword?
Williams LaVonn A
Mar/Apr 2010
Pg. 105-107

Growing a Compounding Practice: Successful Marketing to Underserved Populations
McKettrick Greg
, Yoch Doug
Jul/Aug 2021
Pg. 270-274

Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women
Mason Dave
Jul/Aug 2002
Pg. 255-256

Medical Therapy for Acquired Urinary Incontinence in Dogs
Hill Katie
, Jordan Dinah, Ray Jody, Mays Andrew A, Griffin Katie
Sep/Oct 2012
Pg. 369-375

Compounding Opportunities in Urology
Biundo Bruce
Sep/Oct 2017
Pg. 358-362

Andropause: New Perspectives
Biundo Bruce
May/Jun 2004
Pg. 175-178

Sensitization Therapy for Warts
Kuntz Rachael
Jul/Aug 2003
Pg. 266-270

Treatment Options for Male Hypogonadism
Biundo Bruce
Jan/Feb 2013
Pg. 28-38

Five Compounds for Treating Diabetes-Related Conditions
Meece Jerry
May/Jun 2003
Pg. 170-174

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Male Impotency and the Compounding Pharmacist
Preckshot John
Mar/Apr 1999
Pg. 80-83

Hormone Treatment Options for Males: What to Do for Men with Low Testosterone
Biundo Bruce
Jul/Aug 2009
Pg. 276-279

Men's Health: Practical Solutions to a Profoundly Underrated Health-Care Crisis
Milner Martin
Mar/Apr 1999
Pg. 76-79

Hormonal Influences in Prostate Cancer: An Update of a Complex Subject
Biundo Bruce
Mar/Apr 2010
Pg. 100-104

Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
Nov/Dec 2019
Pg. 492

Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum
Zur Eyal
Mar/Apr 2012
Pg. 117-124